BrightGene Bio-Medical Technology

BrightGene Bio-Medical Technology Co., Ltd (stock code: 688166) is an innovative pharmaceutical enterprise participating in international competition. Relying on R&D drive, the company focuses on the first imitation, difficult imitation, characteristic APIs, complex preparations and original new drugs, continues to create high-tech barriers, gradually establishes a business system that integrates APIs and preparations, combines generic drugs with innovative drugs, and pays equal attention to the international market and domestic market, and is committed to meeting the unmet clinical needs of patients worldwide.

Products & Services

2-[(1S,2S)-1-ethyl-2-benzyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one (posaconazole intermediate POB)

2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylene cyclopentyl]-6H-purine-6-one(ET1)

(3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate(posaconazole intermediate poa)

Amphotericin

Anidulafungin

Country

People's Republic of China

Show site details

BrightGene Pharmaceutical

Country

People's Republic of China

City

Suzhou

Sites